RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle
formulation, work in different ways to stop the growth of tumor cells, either by killing the
cells or by stopping them from dividing. Pemetrexed may stop the growth of tumor cells by
blocking some of the enzymes needed for cell growth. Giving paclitaxel albumin-stabilized
nanoparticle formulation together with pemetrexed may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of paclitaxel
albumin-stabilized nanoparticle formulation when given together with pemetrexed and to see
how well they work in treating patients with advanced non-small cell lung cancer, breast
cancer, or other solid tumors.